Literature DB >> 35576211

Appropriate relaxation of non-pharmaceutical interventions minimizes the risk of a resurgence in SARS-CoV-2 infections in spite of the Delta variant.

Wadim Koslow1, Martin J Kühn1,2, Sebastian Binder2, Margrit Klitz1, Daniel Abele1, Achim Basermann1, Michael Meyer-Hermann2.   

Abstract

We analyze the relaxation of non-pharmaceutical interventions (NPIs) under an increasing number of vaccinations in Germany. For the spread of SARS-CoV-2 we employ a SIR-type model that accounts for age-dependence and includes realistic contact patterns between age groups. The implementation of NPIs occurs on changed contact patterns, improved isolation, or reduced infectiousness when, e.g., wearing masks. We account for spatial heterogeneity and commuting activities in between regions in Germany, and the testing of commuters is considered as a further NPI. We include the ongoing vaccination process and analyze the effect of the B.1.617.2 (Delta) variant, which is considered to be 40%-60% more infectious then the currently dominant B.1.1.7 (Alpha) variant. We explore different opening scenarios under the ongoing vaccination process by assuming that local restrictions are either lifted in early July or August with or without continued wearing of masks and testing. Our results indicate that we can counteract the resurgence of SARS-CoV-2 despite the Delta variant with appropriate timing for the relaxation of NPIs. In all cases, however, school children are hit the hardest.

Entities:  

Mesh:

Year:  2022        PMID: 35576211      PMCID: PMC9135349          DOI: 10.1371/journal.pcbi.1010054

Source DB:  PubMed          Journal:  PLoS Comput Biol        ISSN: 1553-734X            Impact factor:   4.779


  30 in total

1.  Risking further COVID-19 waves despite vaccination.

Authors:  Sebastian Contreras; Viola Priesemann
Journal:  Lancet Infect Dis       Date:  2021-03-18       Impact factor: 25.071

2.  Inferring the structure of social contacts from demographic data in the analysis of infectious diseases spread.

Authors:  Laura Fumanelli; Marco Ajelli; Piero Manfredi; Alessandro Vespignani; Stefano Merler
Journal:  PLoS Comput Biol       Date:  2012-09-13       Impact factor: 4.475

3.  BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.

Authors:  Noa Dagan; Noam Barda; Eldad Kepten; Oren Miron; Shay Perchik; Mark A Katz; Miguel A Hernán; Marc Lipsitch; Ben Reis; Ran D Balicer
Journal:  N Engl J Med       Date:  2021-02-24       Impact factor: 91.245

4.  Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study.

Authors:  Anika Singanayagam; Seran Hakki; Jake Dunning; Kieran J Madon; Michael A Crone; Aleksandra Koycheva; Nieves Derqui-Fernandez; Jack L Barnett; Michael G Whitfield; Robert Varro; Andre Charlett; Rhia Kundu; Joe Fenn; Jessica Cutajar; Valerie Quinn; Emily Conibear; Wendy Barclay; Paul S Freemont; Graham P Taylor; Shazaad Ahmad; Maria Zambon; Neil M Ferguson; Ajit Lalvani
Journal:  Lancet Infect Dis       Date:  2021-10-29       Impact factor: 25.071

5.  Regional opening strategies with commuter testing and containment of new SARS-CoV-2 variants in Germany.

Authors:  Martin J Kühn; Daniel Abele; Sebastian Binder; Kathrin Rack; Margrit Klitz; Jan Kleinert; Jonas Gilg; Luca Spataro; Wadim Koslow; Martin Siggel; Michael Meyer-Hermann; Achim Basermann
Journal:  BMC Infect Dis       Date:  2022-04-04       Impact factor: 3.090

6.  Age-dependent effects in the transmission and control of COVID-19 epidemics.

Authors:  Petra Klepac; Yang Liu; Nicholas G Davies; Kiesha Prem; Mark Jit; Rosalind M Eggo
Journal:  Nat Med       Date:  2020-06-16       Impact factor: 53.440

7.  Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality.

Authors:  Mehul D Patel; Erik Rosenstrom; Julie S Ivy; Maria E Mayorga; Pinar Keskinocak; Ross M Boyce; Kristen Hassmiller Lich; Raymond L Smith; Karl T Johnson; Paul L Delamater; Julie L Swann
Journal:  JAMA Netw Open       Date:  2021-06-01

8.  Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers : A Randomized Controlled Trial.

Authors:  Henning Bundgaard; Johan Skov Bundgaard; Daniel Emil Tadeusz Raaschou-Pedersen; Christian von Buchwald; Tobias Todsen; Jakob Boesgaard Norsk; Mia M Pries-Heje; Christoffer Rasmus Vissing; Pernille B Nielsen; Ulrik C Winsløw; Kamille Fogh; Rasmus Hasselbalch; Jonas H Kristensen; Anna Ringgaard; Mikkel Porsborg Andersen; Nicole Bakkegård Goecke; Ramona Trebbien; Kerstin Skovgaard; Thomas Benfield; Henrik Ullum; Christian Torp-Pedersen; Kasper Iversen
Journal:  Ann Intern Med       Date:  2020-11-18       Impact factor: 25.391

9.  Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution.

Authors:  Martin J Kühn; Daniel Abele; Tanmay Mitra; Wadim Koslow; Majid Abedi; Kathrin Rack; Martin Siggel; Sahamoddin Khailaie; Margrit Klitz; Sebastian Binder; Luca Spataro; Jonas Gilg; Jan Kleinert; Matthias Häberle; Lena Plötzke; Christoph D Spinner; Melanie Stecher; Xiao Xiang Zhu; Michael Meyer-Hermann; Achim Basermann
Journal:  Math Biosci       Date:  2021-06-30       Impact factor: 2.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.